* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
Person Signing this Report on Behalf of Reporting Manager:
Name
Title
City, State
Date
Adam Fliss
Founding Partner and General Counsel
Menlo Park, California
13 Feb 2023
Information regarding the Reporting Manager's holdings in securities of Eargo Inc. as of December 31, 2022 does not reflect a reverse stock split effectuated by Eargo Inc. after December 31, 2022. Certain of the shares reported in the Reporting Manager's holdings in securities of Roivant Sciences Ltd. are subject to vesting conditions that include share price thresholds that may never be satisfied.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.